» NeuroPhage to Participate on Neuroscience Drug Development Panel at MassBio Annual Meeting March 27, 2015

CAMBRIDGE, Mass., March 20, 2015 /PRNewswire/ -- NeuroPhage Pharmaceuticals, Inc., today announced that Jonathan Solomon, CEO, will participate on an expert panel, "Neuroscience Therapeutics Development: Challenges, Opportunities and the Road Ahead," at the Massachusetts...

» Altering brain chemistry makes us more sensitive to inequality
Study finds that prolonging dopamine's effects in the brain boosts compassionWhat if there were a pill that made you more compassionate and more likely to give spare change to someone less...

» Psychedelic drug use 'does not increase risk for mental health problems'
A new study suggests that the stereotype of LSD users developing psychosis is largely a myth, and that the drug may even have some beneficial properties.